Plioplys, A V, Plioplys, S, Davis, J S · Hospital practice (1995) · 1997 · DOI
This article discusses the challenges that ME/CFS patients face, including long-lasting disability and doctors who may not understand or believe in the condition. The authors explain that while there are no blood tests that definitively prove ME/CFS, doctors can confidently diagnose it using established criteria and ruling out other diseases. They suggest that medications can help manage symptoms while patients work toward recovery.
This work addresses a critical gap between patient experience and physician understanding, validating the legitimacy of ME/CFS diagnosis despite the lack of biological markers. It provides practical guidance for clinicians on how to confidently diagnose ME/CFS and support patients, which is essential given the widespread skepticism patients encounter in healthcare settings.
As a case report commentary, this study does not provide controlled evidence about treatment efficacy, long-term prognosis rates, or biological mechanisms underlying ME/CFS. It does not establish which laboratory studies are most useful in excluding other conditions, nor does it prove that symptomatic medication alone leads to recovery.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →